At the weekend I wrote about how successful $20,000 investments in a number of popular ASX shares had been over the last 10 years. You can read about those investments here.
But that was then, what about the next decade?
Listed below are three ASX shares that I believe could provide market-beating returns for investors throughout the 2020s. Here's why I would invest $20,000 into them:
BetaShares Asia Technology Tigers ETF (ASX: ASIA)
I think investors ought to consider putting $20,000 into the BetaShares Asia Technology Tigers ETF. This exchange trade fund gives investors exposure to some of the most exciting technology companies in the Asian market. These include search engine company Baidu, ecommerce stars Alibaba and JD.com, electronics giant Samsung, and WeChat owner Tencent Holdings. These companies are revolutionising the lives of billions of people in the region and look particularly well-placed for growth in the future. In light of this, I believe there's a strong probability the BetaShares Asia Technology Tigers ETF will outperform the ASX 200 by a decent margin throughout the 2020s.
Cochlear Limited (ASX: COH)
I think Cochlear shares would also be a great place to invest $20,000. It is a global developer, manufacturer, and distributor of cochlear implantable devices for the hearing impaired. I think Cochlear would be a great long term option due to the ageing populations tailwind. This is because as people age, their hearing will more often than not fade and require some form of assistance. So, with the World Health Organization estimating that there will be almost three times more people over the age of 65 by 2050 than there were in 2010, demand for Cochlear's industry-leading cochlear implantable devices looks likely to grow strongly over the next few decades.
SEEK Limited (ASX: SEK)
A final ASX share to consider investing $20,000 into is this job listings company. I believe the SEEK share price could generate very strong returns for investors over the 2020s. This is thanks to the strength of its core ANZ business, its investment in growth opportunities, and its fast-growing Chinese operations. Combined, I expect them to drive strong earnings growth over the period. And while FY 2020 will be a disappointing year because of the pandemic, I believe it is worth dealing with the short term pain for the potential long term gains.
